ID: MRFR/F-B & N/7117-CR | 150 Pages | Published By Snehal Singh on November 2019
The Chitin, Chitosan, and Derivatives Market has witnessed significant growth over the last few years and is projected to reach USD 8,987.8 Million by 2030 at a CAGR of 14.8 % from 2022 to 2030.
$ 8,987.8 Million
14.8 %
North America
2022-2030
Chitin, Chitosan and Derivatives Market has witnessed significant growth over the last few years and is projected to reach by USD 8,531.7 Million by 2025 at a CAGR of 8.7% from 2019 to 2025. Chitin is a natural polysaccharide found in crustacean shells, insect skin, and the cell walls of fungal species. Its derivatives such as chitosan and glucosamine find application in various industries. The global chitin, chitosan, and derivatives market is highly competitive with key industry players focusing on product portfolios, regional presence, strategic alliances, and industry experience. The key players are taking steps toward business expansions and market development, expanding their customer base. The international players may strengthen their presence worldwide through acquisitions during the review period.
Market Dynamics
Naturally obtained chitin and its derivatives are widely used in various application industries such as food & beverages, personal care, pharmaceuticals, nutraceuticals, textile, wastewater treatment, paper manufacturing, and agriculture. Thus, the wide application scope of chitin and its derivatives is fueling the growth of the global chitosan, and derivatives market. The abundant availability of raw material is another factor driving the growth of the market as it ensures the continuous and economical supply of raw material.
Global Chitin, Chitosan, and Derivatives Market Share, by Type, 2018 (%) Â
Source: MRFR Analysis
Segmentation
The Global Chitin, Chitosan, and Derivatives Market has been segmented on the Basis of Type, Application, and Region.
Based on type, the market has been segregated into chitin, chitosan, glucosamine, and others. The chitosan segment accounted for the largest market share in 2018. The dominance of the segment can be attributed to the high demand for chitosan in various application industries such as food & beverages, agriculture, aquaculture, food packaging, water treatment, and pharmaceuticals. By application, the market has been divided into food & beverages, pharmaceuticals & nutraceuticals, animal feed, agriculture, and others. The food & beverages segment is projected to be the fastest growing during the forecast period owing to the rising consumption of natural food products and beverages, mainly in North America and Europe.
Chitin, Chitosan, and Derivatives Market Size, by Application, 2017–2025 (USD Million) Â
Sources: MRFR Analysis
Regional Analysis
On the basis of region, the Global Chitin, Chitosan and Derivatives Market has been categorized as North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America accounted for the largest market share in 2018 while the market in Asia-Pacific is expected to register the highest CAGR during the review period. Growing health consciousness and increasing awareness regarding the benefits of chitin, chitosan, and their derivatives are the key factors driving the growth of the North American market. The presence of numerous pharmaceutical and nutraceutical manufacturers in North America is another factor boosting the consumption of chitin, chitosan, and derivatives in the region, with the US being the largest country-level Chitin Market.
Key Players
The Prominent Players in the Global Chitin, Chitosan and Derivatives Market include Advanced Biopolymers AS (Norway), G.T.C. Bio Corporation (China), Golden-Shell Pharmaceutical Co. Ltd. (China), Heppe Medical Chitosan GmbH (Germany), Kitozyme, LLC (Belgium), Zhejiang Shinfuda Marine Biotechnology Corp. (China), Meron Group (India), Primex EHF (Iceland), Zhejiang Candorly Pharmaceutical Co. (China), and Panvo Organics Pvt Ltd (India).
Chitin, Chitosan and Derivatives Market Segmentation
Global Chitin, Chitosan, and Derivatives Market, by Type
Global Chitin, Chitosan, and Derivatives Market, by Application
Global Chitin, Chitosan, and Derivatives Market, by Region
Available Additional Customizations
Intended Audience
Report Attribute/Metric | Details |
---|---|
Market Size | USD 8,531.7 Million (2025) |
CAGR | 8.7% (2019-2025) |
Base Year | 2019 |
Forecast Period | 2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Application |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Advanced Biopolymers AS (Norway), G.T.C. Bio Corporation (China), Golden-Shell Pharmaceutical Co. Ltd. (China), Heppe Medical Chitosan GmbH (Germany), Kitozyme, LLC (Belgium), Zhejiang Shinfuda Marine Biotechnology Corp. (China), Meron Group (India), Primex EHF (Iceland), Zhejiang Candorly Pharmaceutical Co. (China), and Panvo Organics Pvt Ltd (India). |
Key Market Opportunities | Growing health consciousness |
Key Market Drivers | The abundant availability of raw material |